These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31787850)

  • 21. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
    Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
    Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.
    Yang Q; Sun J; Ma Y; Zhao C; Song J
    Am J Transl Res; 2019; 11(11):7009-7017. PubMed ID: 31814904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
    Li X; Zhang H; Wu X
    Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis.
    Kong WQ; Liang JJ; Du J; Ye ZX; Gao P; Liang YL
    Cancer Biother Radiopharm; 2021 Nov; 36(9):753-764. PubMed ID: 32379493
    [No Abstract]   [Full Text] [Related]  

  • 26. Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.
    Zhong ZB; Wu YJ; Luo JN; Hu XN; Yuan ZN; Li G; Wang YW; Yao GD; Ge XF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10867-10873. PubMed ID: 31858555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.
    Tian Y; Wang YR; Jia SH
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7307-7313. PubMed ID: 31539117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
    Wu SB; Wang HQ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
    Qian Y; Song W; Wu X; Hou G; Wang H; Hang X; Xia T
    Dig Dis Sci; 2021 Feb; 66(2):460-473. PubMed ID: 32239379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
    Bao J; Zhang S; Meng Q; Qin T
    Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis.
    Liu L; Zhao H; He HH; Huang J; Xu YY; Li XL; Wu Y; Wang J; Zhu YB
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12748-12756. PubMed ID: 33378023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C; Li K; Huang R; Zhu J; Yang J
    Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.
    Liu L; Zhou T; Li T; Liang Z; Luo X
    Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer.
    Zhu X; Ma X; Zhao S; Cao Z
    Environ Toxicol; 2021 Mar; 36(3):308-319. PubMed ID: 33035382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
    Xu C; Zhai J; Fu Y
    Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.